In terms of efficacy evaluation indexes, the levels of tumor markers CA125, CEA, and CA199 decreased significantly after treatment compared with before treatment, and the blood routine indexes (D-dimer, CRP, NLR, and MLR) decreased after treatment compared with before treatment, indicating that hematological indexes had certain value in evaluating the efficacy of this treatment regimen. The gene discussed is CRP; the disease is neoplasm.